查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1624409

全球蜂窝分析市场规模（按产品类型、蜂窝类型、最终用户、地区、范围和预测）

Global Cell Analysis Market Size By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells, Microbial Cells), By End-User (Biotechnology Companies, Hospitals, Cell Banks), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

细胞分析市场规模及预测

2021 年细胞分析市场规模价值为 160.7 亿美元，预计到 2030 年将达到 383.4 亿美元，2023 年至 2030 年的复合年增长率为 10.15%。增加政府对细胞研究的资助是增加细胞分析市场收入的关键方面，而单细胞分析产品的技术进步则推动市场成长。全球蜂窝分析市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

定义全球细胞分析市场

细胞分析在单细胞层级研究生物的基因组、代谢组学、转录组学和蛋白​​质组学。单细胞分析用于测量、分析和定序单细胞异质性的人类基因组。萤光活化细胞分选技术从复杂样本中分离出选定的单细胞。在临床诊断中，细胞分析有望实现工作流程的标准化和自动化，为癌症的即时监测提供有价值的信息，并最终为患者带来新的治疗策略。

细胞分析对于基因鑑定、蛋白质鑑定、表观基因组学和其他相关生命科学领域至关重要。提高细胞成像和分析系统的准确性有助于加快药物研发过程并降低成本。如今，大多数地方都是以批量方式分析细胞，每个样本包含数千个细胞，并根据细胞的平均反应来分析结果。因此，为了进行实用且精确的细胞分析，必须考虑单一细胞究竟如何反应。

全球细胞分析市场概览

医疗产业的发展和癌症发生率的上升推动了细胞分析市场的发展。此外，技术先进产品的引进以及医院、诊断实验室等的兴起也推动了市场的成长。此外，细胞分析在诊断应用的采用越来越多，也是推动全球细胞分析市场发展的关键因素。此外，政府对细胞研究的投资和资助不断增加也是推动全球市场成长的其他因素。

此外，传染病、慢性病和神经系统疾病的日益普及是推动全球细胞分析市场成长的正面预测。还有一些课题阻碍了整个市场的成长。设备成本高等因素阻碍了市场成长。市场面临的另一个主要课题是小企业和新进者的生存。然而，体细胞研究和细胞定序的研究和开发预计将为全球细胞分析市场的主要参与者提供丰厚的商机。

目录

第 1 章 全球蜂窝分析市场简介

    市场概况
  • 研究范围
  • 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

  • 资料探勘
  • 验证
  • 主要来源
  • 资料来源列表

第 4 章全球细胞分析市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 阻碍因素
    • 机会
  • 波特五力模型
  • 价值链分析
  • 监理框架

第 5 章全球细胞分析市场（依产品划分）
  • 概述
  • 消耗品
    • 试剂 检测试剂盒
    • 微孔板
    • 其他
  • 检查设备
    • 显微镜 流式细胞仪
    • 分光光度计 定量PCR
    • 细胞计数器
    • HCS 系统
    • 细胞微阵列

第6章 全球细胞分析市场（依细胞类型）

  • 概述
  • 人类细胞
  • 动物细胞
  • 微生物细胞

第 7 章 全球蜂窝分析市场（按最终用户划分）

  • 概述
  • 生技公司
  • 医院
  • 细胞库
  • 其他

第 8 章 全球蜂窝分析市场（按区域）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
    亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 世界其他地区
    • 中东和非洲

第 9 章全球细胞分析市场（按细胞类型）
  • 概述
  • 公司市占率
  • 供应商概况
  • 主要发展策略

第10章 公司简介

  • Becton, Dickinson and Company
  • Merck KGAA
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Agilent Technologies, Inc.
  • Olympus Corporation
  • Perkinelmer, Inc.
  • Promega Corporation
  • Tecan Group Ltd.

第 11 章 重大进展

  • 产品发布/开发
  • 合併和收购
  • 业务扩展
  • 伙伴关係和合作关係

第 12 章附录

  • 相关研究
简介目录
Product Code: 24214

Cell Analysis Market Size And Forecast

Cell Analysis Market size was valued at USD 16.07 Billion in 2021 and is projected to reach USD 38.34 Billion by 2030 , growing at a CAGR of 10.15% from 2023 to 2030. The increasing government funding for cell-based research is the crucial aspect of the rise in the market revenue of Cell Analysis as well as the technological advancements in single-cell analysis products that will foster market growth. The Global Cell Analysis Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cell Analysis Market Definition

Cell Analysis studies the genomics, metabolomics, transcriptomics, and proteomics of a living being at a single-cell level. The single-Cell Analysis is used in measuring, analyzing, and sequencing the human genome at a single-cell heterogeneity. Fluorescence-activated cell sorting isolates the selected single cells from complex samples. In clinical diagnostics, Cell Analysis is expected to standardize and automate workflows with valuable information for real-time monitoring of cancer and, eventually, new therapeutic strategies for the benefit of patients.

Cellular Analysis is vital in gene identification, protein identification, epigenomics, and other life science-related areas. Enhanced accuracy of cell imaging and analysis systems helps reduce the drug discovery process time and price. Today in most places, cells are analyzed in masses with thousands of cells per sample, and results are analyzed based on the average response of the cells. Hence to get practical and accurate Cell Analysis, it's essential to review how exactly individual cells respond.

Global Cell Analysis Market Overview

The Growth of the Cell Analysis Market is driven by the development of the healthcare industry and the rise in cancer incidence. Furthermore, the introduction of technologically advanced products and an increased number of hospitals, diagnostic laboratories, and others fuel the market growth. Moreover, increasing the adoption of Cell Analysis for diagnostic applications is a significant factor driving the development of the global Cell Analysis Market. Moreover, rising government investments and funding for cell-based research are other factors fueling the growth of the worldwide market.

Moreover, the increasing prevalence of infectious & chronic diseases and neurological disorders has positively anticipated propelling the growth of the global Cell Analysis Market. There are specific challenges faced that will hinder the overall market growth. Factors such as the high cost of instruments inhibit the market's growth. Also, the survival of small players and new entrants is the major challenge faced by the market. However, research and development in somatic cell research and cell sequencing may be expected to present lucrative business opportunities for major players within the global Cell Analysis Market.

Global Cell Analysis Market Segmentation Analysis

The Global Cell Analysis Market is segmented based on Product, Cell Type, End-User, And Geography.

Cell Analysis Market, By Product

  • Consumables
  • Instruments

Based on Product, the market is bifurcated into Consumables and Instruments. The consumables segment holds the largest market share during the forecast period. The factors that can be attributed to the frequent purchase of these products as compared to instruments, which are considered as a one-time investment, and their wide applications in research and genetic exploration, exosome analysis, and isolation of RNA and DNA are accelerating the demand for consumables segment.

Cell Analysis Market, By Cell Type

  • Human Cells
  • Animal Cells
  • Microbial Cells

Based on Cell Type, the market is bifurcated into Human Cells, Animal Cells, and Microbial Cells. The human cells segment holds the largest market share. The factors that can be attributed to the high utilization of human cells in research laboratories and academic institutes are accelerating the demand.

Cell Analysis Market, By End-User

  • Biotechnology Companies
  • Hospitals
  • Cell Banks
  • Others

Based on End-User, the market is bifurcated into Biotechnology Companies, Hospitals, Cell Banks, and Others. The academic and research laboratories segment holds the largest market share during the forecast period. The factors that can be attributed to growth in funding for all times science research and therefore the increasing number of medical colleges and universities enhance the demand for academic and research laboratories segment.

Cell Analysis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of The World
  • On the basis of Geography, the Global Cell Analysis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia-Pacific holds the largest market share. The Asia Pacific market is anticipated to witness the highest growth during the forecast period. The presence of a large patient population (especially in China and India), increasing investments in R&D, growth in the outsourcing of drug discovery services to Asian CROs, strong governmental initiatives, and ongoing projects will boost the market in the APAC region.

Key Players

  • The "Global Cell Analysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Becton, Dickinson and Company, Merck KGAA, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Agilent Technologies, Inc., Olympus Corporation, Perkinelmer, Inc., Promega Corporation, and Tecan Group Ltd.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Product Launches and Product Expansions
  • In April 2018, BD (Becton, Dickinson and Business), a leading worldwide medical technology company, announced the launch of the BD FACSymphony(TM) S6 cell sorter, which will be on exhibit at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform takes advantage of the BD FACSymphony cell analyzer's high parameter capabilities, allowing researchers to sort cell populations to better understand cell phenotypes for immunology and multi-omics research.
  • In May 2018, Beckman Coulter Life Sciences introduced the Kaluza C Flow Cytometry Analysis Software, a sophisticated data analysis system for clinical laboratories. The new program simplifies clinical QC reporting and addresses flow cytometry standardization difficulties.
  • In September 2018, Leica Microsystems established the first Imaging Center in San Francisco. This facility will showcase the spectrum of technology in microscopes produced by Leica Microsystems for life sciences research.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CELL ANALYSIS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CELL ANALYSIS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL CELL ANALYSIS MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Consumables
    • 5.2.1 Reagents
    • 5.2.2 Assay Kits
    • 5.2.2.1 Immuno assays
    • 5.2.2.2 Cell based assays
    • 5.2.3 Microplates
    • 5.2.4 Others
  • 5.3 Instruments
    • 5.3.1 Microscopes
    • 5.3.2 Flow cytometry
    • 5.3.3 Spectrophotometers
    • 5.3.4 qPCR
    • 5.3.5 Cell Counters
    • 5.3.6 HCS Systems
    • 5.3.7 Cell Microarrays

6 GLOBAL CELL ANALYSIS MARKET, BY CELL TYPE

  • 6.1 Overview
  • 6.2 Human Cells
  • 6.3 Animal Cells
  • 6.4 Microbial Cells

7 GLOBAL CELL ANALYSIS MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Biotechnology Companies
  • 7.3 Hospitals
  • 7.4 Cell Banks
  • 7.5 Others

8 GLOBAL CELL ANALYSIS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Argentina
  • 8.6 Rest of the World
    • 8.6.1 Middle East and Africa

9 GLOBAL CELL ANALYSIS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Share
  • 9.3 Vendor Landscape
  • 9.4 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Becton, Dickinson and Company
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Merck KGAA
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Thermo Fisher Scientific, Inc.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Danaher Corporation
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 GE Healthcare
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Agilent Technologies, Inc.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Olympus Corporation
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Perkinelmer, Inc.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Promega Corporation
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Tecan Group Ltd.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research